Fundraising Fox
Sethera Therapeutics
Salt Lake City, US · Founded 2024 · Delaware corporation
Find your way into Sethera Therapeutics
Sign up to see every warm intro you have to Sethera Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sethera Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sethera Therapeutics develops peptide-based therapeutics using innovative enzyme chemistry research. The company focuses on commercializing novel peptide drugs derived from breakthrough scientific discoveries.
Founders & leadership
YK
Yakov KoganExecutive
VB
Vahe BandarianCSO and President
KE
Karsten EastmanCEO
CT
Cynthia TsaiNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.9M disclosed across 1 round · 2024
▶$1.9MraisedOct 2024 · 21 investors · BiotechnologyRule 506(b)
▶$1.9MraisedOct 2024 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Vahe BandarianExecutive Officer, Director
- Karsten EastmanExecutive Officer, Director
- Cynthia TsaiExecutive Officer, Director
- Yakov KoganExecutive Officer
- Offering amount
- $3M
- Amount sold
- $1.9M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
AltaThera PharmaceuticalsAltaThera develops intravenous antiarrhythmic therapies for treating cardiac conditions including atrial fibrillation and ventricular tachycardia. The company's lead product, Sotalol IV, enables faster patient assessment and potential outpatient discharge compared to oral alternatives.
RayTheraA biopharmaceutical company developing therapies for neurology, immunology, and rare diseases. The page describes work focused on treating hard-to-treat conditions.
ExThera Medical
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies working in the same space as Sethera Therapeutics.
In the news
Frequently asked questions
- What does Sethera Therapeutics do?
- Sethera Therapeutics develops peptide-based therapeutics using innovative enzyme chemistry research. The company focuses on commercializing novel peptide drugs derived from breakthrough scientific discoveries.
- How much funding has Sethera Therapeutics raised?
- Sethera Therapeutics has disclosed $1.9M raised across 1 round.
- Where is Sethera Therapeutics headquartered?
- Sethera Therapeutics is headquartered in Salt Lake City, US.